19-39173219-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005884.5(PAK4):c.506G>A(p.Gly169Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000025 in 1,559,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005884.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAK4 | NM_005884.5 | c.506G>A | p.Gly169Asp | missense_variant | 4/10 | ENST00000360442.8 | NP_005875.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAK4 | ENST00000360442.8 | c.506G>A | p.Gly169Asp | missense_variant | 4/10 | 5 | NM_005884.5 | ENSP00000353625.3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000442 AC: 7AN: 158208Hom.: 0 AF XY: 0.0000462 AC XY: 4AN XY: 86572
GnomAD4 exome AF: 0.0000192 AC: 27AN: 1407332Hom.: 0 Cov.: 33 AF XY: 0.0000245 AC XY: 17AN XY: 694896
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2024 | The c.506G>A (p.G169D) alteration is located in exon 5 (coding exon 2) of the PAK4 gene. This alteration results from a G to A substitution at nucleotide position 506, causing the glycine (G) at amino acid position 169 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at